PRTK — Paratek Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- $127.83m
- $343.47m
- $160.27m
Annual cashflow statement for Paratek Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -112 | -129 | -96.5 | -59.1 | -63.6 |
| Depreciation | |||||
| Non-Cash Items | 27.3 | 16.5 | 12.8 | 18.6 | 17.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.92 | -21.7 | -20.3 | -8.19 | -20.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -81.2 | -134 | -103 | -48.3 | -66.1 |
| Capital Expenditures | -0.06 | -0.239 | -0.376 | -0.373 | -0.036 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -128 | 135 | 92.9 | 4.88 | 14.8 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -128 | 135 | 92.5 | 4.51 | 14.8 |
| Financing Cash Flow Items | — | — | — | — | 0.646 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 221 | 57.6 | 11.3 | 18.3 | 5.09 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.7 | 58.1 | 0.415 | -25.4 | -46.2 |